Consultant Physician and Endocrinologist MBBS (Hons), MRCP(UK), MRCP(Endocrinology), FRCP(Edin), FRCP(London) CCT in GIM, Diabetes & Endocrinology
A quick overview for ADA 2024 SOC ..
Watch as Dr. Robert Gabbay MD, PhD gives us an overview of the 2024 Standards of Care in Diabetes- Pharmacologic Approach to Glycemic Treatment. For this and more visit: https://lnkd.in/g3TzxbuT
Watch as Dr. Robert Gabbay MD, PhD gives us an overview of the 2024 Standards of Care in Diabetes- Pharmacologic Approach to Glycemic Treatment. For this and more visit: https://lnkd.in/g3TzxbuT
Watch as Dr. Robert Gabbay MD, PhD gives us an overview of the 2024 Standards of Care in Diabetes- Pharmacologic Approach to Glycemic Treatment. For this and more visit: https://lnkd.in/g3TzxbuT
🧐We welcome you to read "Fatigue: #Pharmacological and non-pharmacological management in patients with multiple #sclerosis" 👥By Kubra Yeni et al. Read #article here: https://lnkd.in/gcz6RifC
Understanding antimicrobial pharmacokinetics in critically ill patients to optimize antimicrobial therapy CCR Journal Watch https://lnkd.in/eNVJSqUi Get the latest critical care literature every weekend via the CCR Newsletter - subscribe at https://lnkd.in/eXDDjbUa
Sepsis Diagnostics Market Surges to USD 891.05 Million by 2031, Propelled by 7% CAGR - Verified Market Research® The market for sepsis diagnostics is propelled by multiple factors, such as the increasing prevalence of sepsis, the growing awareness among medical professionals, and advancements in diagnostic techniques. The prohibitive costs of diagnostic testing, stringent regulatory requirements, and challenges in early diagnosis brought on by non-specific symptoms are some of the constraints. bit.ly/3wuqcfE
Research shows PGx testing can improve therapeutic outcomes for a remarkable 65-70% of patients! 🤯 By understanding your unique genetic makeup, your medication can be tailored to maximise its effectiveness and minimise side effects. This is personalised medicine in action. (Based on findings from PMID: 29529627) #PGxTesting #PersonalisedMedicine #Research #Mantara #YourHealth
New Consensus on Hemoadsorption Therapy for Rhabdomyolysis! 🚀 We’re glad to share the latest expert consensus on using CytoSorb® in rhabdomyolysis, published in BMC Nephrol. 🔍 Key Takeaways: - Results: CytoSorb® prevents and reduces Acute Kideny Injury (AKI) led by excessive concentration of myoglobin - Patients profile: myoglobin >10.000ng/ml: use Cytosorb® within 12-24 h from diagnosis - Therapy: change sorbent every 8-12 h until myoglobin levels are stably <5.000 ng/ml The Hemoadsorbtion Rhabdomyolysis Task Force's findings confirm the effectiveness of CytoSorb® in reducing myoglobin. 👉 https://bit.ly/3Xu31MW Don’t forget our 𝐂𝐚𝐥𝐥 𝐟𝐨𝐫 𝐀𝐛𝐬𝐭𝐫𝐚𝐜𝐭𝐬: present your research at the 𝐖𝐨𝐫𝐤𝐬𝐡𝐨𝐩 𝐏𝐮𝐫𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬 in Milan, September 26ᵗʰ and 27ᵗʰ, 2025. Submit your abstract here purification.therapies@aferetica.com #Aferetica #ScientificLiterature #CriticalCare #WPT #Healthcare
Ready to start your renal impairment PK study? Discover how Celerion's expertise can streamline your study design, saving time and budget. Read Now -> https://lnkd.in/ev28i9hc #RenalStudies #ClinicalTrials #PKStudies #Pharmacokinetics
Our practice-integrated research program is one of the most active endocrine research practices worldwide. Learn about our currently enrolling clinical trials to see if you meet study requirements. https://shorturl.at/J3awy #clinicalresearch #diabetesresearch #endocrineresearch #researchstudies #clinicaltrial #texasdiabetes
This review provides current evidence regarding the potential benefits of TDM in IFI management. It discusses how TDM can enhance treatment response, safety, and address altered pharmacokinetics in specific patient populations. https://bit.ly/3OWNAZ1
